Africa Races to Make Its Own Vaccines
Africa is racing to make its own vaccines, from South Africa's first homegrown HIV trial to new factories, so it no longer waits at the back of the queue.
Opening excerpt (first ~120 words) tap to expand
Southern Africa Africa Africa Races to Make Its Own Vaccines By Amina Diarra · June 26, 2026 · 5 min read Daily Brief The morning intel from across Latin America. Free. Subscribe By subscribing you agree to our privacy policy. We never share your email. SOUTH AFRICA · SCIENCE Key Facts —Homegrown trial: South Africa has launched its first in-human HIV vaccine trial, a shift from test site to scientific leader. —New factories: Biovac is building one of Africa’s first end-to-end vaccine plants, backed by global lenders. —Fast money: A global coalition pledged $62 million in June to speed African vaccine candidates against a deadly virus. —A continental plan: The Africa CDC is driving the first continent-wide immunisation strategy.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Rio Times.
Discussion
0 commentsMore from The Rio Times
